Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Related Articles by Review for PubMed (Select 15118073)

1.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA.

N Engl J Med. 2004 May 20;350(21):2129-39. Epub 2004 Apr 29.

2.
3.

[Indication of EGFR kinase inhibitors should be refined].

Heneberg P.

Klin Onkol. 2011;24(2):87-93. Review. Czech.

PMID:
21644362
4.

Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive.

Santarpia M, Altavilla G, Salazar MF, Magri I, Pettineo G, Benecchi S, Rosell R.

Expert Rev Respir Med. 2011 Jun;5(3):413-24. doi: 10.1586/ers.11.27. Review.

PMID:
21702662
5.

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.

Gridelli C, De Marinis F, Di Maio M, Cortinovis D, Cappuzzo F, Mok T.

Lung Cancer. 2011 Mar;71(3):249-57. doi: 10.1016/j.lungcan.2010.12.008. Epub 2011 Jan 8. Review.

PMID:
21216486
6.

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].

Shimizu J, Horio Y, Mitsudomi T.

Gan To Kagaku Ryoho. 2005 Nov;32(12):1879-85. Review. Japanese.

PMID:
16282720
7.
8.

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer.

Rosell R, Viteri S, Molina MA, Benlloch S, Taron M.

Curr Opin Oncol. 2010 Mar;22(2):112-20. doi: 10.1097/CCO.0b013e32833500d2. Review.

PMID:
19949333
9.

Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer.

Zhang X, Chang A.

J Med Genet. 2007 Mar;44(3):166-72. Epub 2006 Dec 8. Review.

10.

Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.

Ahmed SM, Salgia R.

Respirology. 2006 Nov;11(6):687-92. Review.

PMID:
17052295
11.

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.

Haber DA, Bell DW, Sordella R, Kwak EL, Godin-Heymann N, Sharma SV, Lynch TJ, Settleman J.

Cold Spring Harb Symp Quant Biol. 2005;70:419-26. Review.

PMID:
16869779
12.

[Gefitinib and epidermal growth factor receptor gene mutation].

Fukui T, Mitsudomi T.

Gan To Kagaku Ryoho. 2007 Aug;34(8):1168-72. Review. Japanese.

PMID:
17687196
13.
14.
15.

[Molecular diagnostics in lung carcinoma for therapy stratification].

Heukamp LC, Büttner R.

Pathologe. 2010 Feb;31(1):22-8. doi: 10.1007/s00292-009-1241-1. Review. German.

PMID:
19997736
16.

Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib.

Heigener DF, Reck M.

Adv Ther. 2011 Feb;28(2):126-33. doi: 10.1007/s12325-010-0096-4. Epub 2010 Dec 16. Review.

PMID:
21181318
17.

Maintenance therapy of gefitinib for non-small-cell lung cancer after first-line chemotherapy regardless of epidermal growth factor receptor mutation: a review in Chinese patients.

Biaoxue R, Shuanying Y, Wei L, Wei Z, Zongjuan M.

Curr Med Res Opin. 2012 Oct;28(10):1699-708. doi: 10.1185/03007995.2012.728525. Epub 2012 Oct 2. Review.

PMID:
22978775
18.

Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours.

Jänne PA.

Lung Cancer. 2008 Jun;60 Suppl 2:S3-9. doi: 10.1016/S0169-5002(08)70099-0. Review.

PMID:
18513582
19.

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.

Roengvoraphoj M, Tsongalis GJ, Dragnev KH, Rigas JR.

Cancer Treat Rev. 2013 Dec;39(8):839-50. doi: 10.1016/j.ctrv.2013.05.001. Epub 2013 Jun 12. Review.

20.

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.

Di Maio M, Gridelli C, Normanno N, Perrone F, Ciardiello F.

J Cell Physiol. 2005 Dec;205(3):355-63. Review.

PMID:
15895392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk